Apria Appoints Christopher G. Lee as Chief Accounting Officer
04 Octubre 2021 - 7:00AM
Apria, Inc. (the “Company” or “Apria”) (Nasdaq: APR), a leading
provider of home medical equipment, supplies and related services
in the United States, announced today the appointment of
Christopher G. Lee as Chief Accounting Officer, a newly created
position. Mr. Lee will report to Debra Morris, Apria’s Chief
Financial Officer.
Mr. Lee has 18 years of accounting and financial leadership
experience. He joined Apria in February 2009 and has risen
internally to his most recent role as Senior Vice President,
Accounting and Finance. Prior to joining Apria, Mr. Lee was with
Deloitte & Touche. Mr. Lee is a graduate of the University of
California at Santa Barbara, where he earned his Bachelor of Arts
in Business Economics and is a member of the American Institute of
Certified Public Accountants (AICPA).
Mr. Lee will oversee all aspects of Apria’s accounting function,
including financial reporting, controls and operations. He will
also continue to lead the development, implementation and
management of enterprise-wide practices, systems and internal
controls.
“As a longtime Apria employee, Chris Lee is woven into the
fabric of the Company both professionally and personally, and we
are incredibly grateful for his contributions over the years,” said
Ms. Morris. “Chris holds a wealth of expertise on the accounting
and financial side of our business, not to mention the experience
he has accrued with Apria over the course of more than a decade.
The entire Apria family congratulates Chris on his new role.”
About Apria
Apria is a leading provider of integrated home healthcare
equipment and related services in the United States. The Company
offers a comprehensive range of products and services for in-home
care and delivery across three core service lines: (1) home
respiratory therapy (including home oxygen and non-invasive
ventilation (“NIV”) services); (2) obstructive sleep apnea
(“OSA”) treatment (including continuous positive airway pressure
(“CPAP”) and bi-level positive airway pressure devices, and patient
support services); and (3) negative pressure wound therapy
(“NPWT”). Additionally, the Company supplies a wide range of home
medical equipment and other products and services to help improve
the quality of life for patients with home care needs. Our revenues
are generated through fee-for-service and capitation arrangements
with third-party healthcare payors, including government and
commercial payors for equipment, supplies, services and other items
we rent or sell to patients. Through our offerings, we also provide
patients with a variety of clinical and administrative support
services and related products and supplies, most of which are
prescribed by a physician as part of a care plan. We are focused on
being the industry’s highest-quality provider of home healthcare
equipment and related services, while maintaining our commitment to
being a low-cost operator. The Company serves over 2 million
patients annually and offers a compelling value proposition to
patients, providers and payors by allowing patients to receive
necessary care and services in the comfort of their own home,
while, at the same time, reducing the costs of treatment. Learn
more at www.apria.com.
Forward-Looking Statements
This press release contains forward-looking statements within
the meaning of Section 27A of the Securities Act of 1933, as
amended, and Section 21E of the Securities Exchange Act of 1934, as
amended. Forward-looking statements include all statements that do
not relate solely to historical or current facts. In some cases,
you can identify these forward-looking statements by the use of
words such as “outlook,” “believes,” “expects,” “potential,”
“continues,” “may,” “will,” “should,” “could,” “seeks,” “predicts,”
“intends,” “trends,” “plans,” “estimates,” “anticipates” or the
negative version of these words or other comparable words. Such
forward-looking statements are subject to various risks and
uncertainties, including, among others, risks related to the
COVID-19 public health emergency, product and related recalls, the
profitability of our capitation arrangements, renegotiation or
termination of our contracts, reimbursements by payors, our
reliance on relatively few vendors, competition in the home
healthcare industry, the inherent risk of liability in the
provision of healthcare services, and reductions in Medicare and
Medicaid and commercial payor reimbursement rates. Additional
factors that could cause our actual outcomes or results to differ
materially from those described in the forward-looking statements
can be found in the “Risk Factors" sections of the Company’s Annual
Report on Form 10-K for the period ended December 31, 2020 and its
Quarterly Report on Form 10-Q for the period on Form 10-Q for the
period ended June 30, 2021, each as filed with the Securities and
Exchange Commission (“SEC”). These reports are or will be
accessible on the SEC’s website at www.sec.gov. These factors
should not be construed as exhaustive and should be read in
conjunction with the other cautionary statements that are included
in this press release and in the Company’s filings with the SEC. We
undertake no obligation to publicly update or review any
forward-looking statement, whether as a result of new information,
future developments or otherwise, except as required by law.
Investor ContactKevin
EllichWestwickeApriaIR@westwicke.com
Media ContactKyle
EvansWestwickeApriaPR@westwicke.com
A photo accompanying this announcement is available at
https://www.globenewswire.com/NewsRoom/AttachmentNg/c5d8025a-fdbc-41b2-94e2-20e1724ffb9c
Apria (NASDAQ:APR)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
Apria (NASDAQ:APR)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024